Related Experiment Video
Updated: Nov 19, 2025

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury
Stéphanie Bieber1,2, Angelina Kraechan3,4, Johannes C Hellmuth4,5
1Medizinische Klinik und Poliklinik I, Klinikum der Universitaet Muenchen, Ludwig-Maximilians-University, Marchioninistraße 15, 81377, Munich, Germany. Stephanie.Bieber@med.uni-muenchen.de.
Insights
COVID-19 can cause heart muscle injury, leading to ventricular dysfunction. Echocardiography revealed impaired left and right ventricular function in patients with myocardial injury, which showed partial recovery over time.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Imaging
Background:
- COVID-19, caused by SARS-COV-2, is a multi-organ disease.
- Myocardial injury is a known complication, but its echocardiographic characteristics are not fully understood.
Purpose of the Study:
- To characterize echocardiographic patterns of ventricular function in patients with COVID-19-associated myocardial injury.
Main Methods:
- Prospective assessment of 32 hospitalized COVID-19 patients using comprehensive 3D and strain echocardiography.
- Patients were categorized based on elevated high-sensitivity troponin T (hsTNT+ vs. hsTNT-).
Main Results:
- 65.7% of patients exhibited left and/or right ventricular dysfunction.
- hsTNT+ patients commonly showed biventricular dysfunction, impaired left ventricular global longitudinal strain (GLS), and reduced right ventricular (RV) systolic function.
- Myocardial dysfunction partially recovered in hsTNT+ patients after 52 days.
Conclusions:
- COVID-19-associated myocardial injury is linked to left and right ventricular dysfunction.
- Echocardiography, particularly 3D and strain imaging, effectively revealed these dysfunctions.
- Ventricular dysfunction showed partial resolution at a 2-month follow-up.
Purpose:
SARS-COV-2 infection can develop into a multi-organ disease. Although pathophysiological mechanisms of COVID-19-associated myocardial injury have been studied throughout the pandemic course in 2019, its morphological characterisation is still unclear. With this study, we aimed to characterise echocardiographic patterns of ventricular function in patients with COVID-19-associated myocardial injury.
Methods:
We prospectively assessed 32 patients hospitalised with COVID-19 and presence or absence of elevated high sensitive troponin T (hsTNT+ vs. hsTNT-) by comprehensive three-dimensional (3D) and strain echocardiography.
Results:
A minority (34.3%) of patients had normal ventricular function, whereas 65.7% had left and/or right ventricular dysfunction defined by impaired left and/or right ventricular ejection fraction and strain measurements. Concomitant biventricular dysfunction was common in hsTNT+ patients. We observed impaired left ventricular (LV) global longitudinal strain (GLS) in patients with myocardial injury (-13.9% vs. -17.7% for hsTNT+ vs. hsTNT-, p = 0.005) but preserved LV ejection fraction (52% vs. 59%, p = 0.074). Further, in these patients, right ventricular (RV) systolic function was impaired with lower RV ejection fraction (40% vs. 49%, p = 0.001) and reduced RV free wall strain (-18.5% vs. -28.3%, p = 0.003). Myocardial dysfunction partially recovered in hsTNT + patients after 52 days of follow-up. In particular, LV-GLS and RV-FWS significantly improved from baseline to follow-up (LV-GLS: -13.9% to -16.5%, p = 0.013; RV-FWS: -18.5% to -22.3%, p = 0.037).
Conclusion:
In patients with COVID-19-associated myocardial injury, comprehensive 3D and strain echocardiography revealed LV dysfunction by GLS and RV dysfunction, which partially resolved at 2-month follow-up.
Trial Registration:
COVID-19 Registry of the LMU University Hospital Munich (CORKUM), WHO trial ID DRKS00021225.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

